• Je něco špatně v tomto záznamu ?

Perinatal hypoxic-ischemic damage: review of the current treatment possibilities

A. Frajewicki, Z. Laštůvka, V. Borbélyová, S. Khan, K. Jandová, K. Janišová, J. Otáhal, J. Mysliveček, V. Riljak

. 2020 ; 69 (Suppl 3) : S379-S401. [pub] 20201231
. 2020 ; 96 (Suppl 3) : S379-S401. [pub] 20201231

Jazyk angličtina Země Česko

Typ dokumentu časopisecké články, přehledy

Perzistentní odkaz   https://www.medvik.cz/link/bmc21028103

Neonatal hypoxic-ischemic encephalopathy is a disorder with heterogeneous manifestation due to asphyxia during perinatal period. It affects approximately 3-12 children per 1000 live births and cause death of 1 million neonates worldwide per year. Besides, motor disabilities, seizures, impaired muscle tone and epilepsy are few of the consequences of hypoxic-ischemic encephalopathy. Despite an extensive research effort regarding various treatment strategies, therapeutic hypothermia with intensive care unit supportive treatment remains the only approved method for neonates who have suffered from moderate to severe hypoxic-ischemic encephalopathy. However, these protocols are only partially effective given that many infants still suffer from severe brain damage. Thus, further research to systematically test promising neuroprotective treatments in combination with hypothermia is essential. In this review, we discussed the pathophysiology of hypoxic-ischemic encephalopathy and delved into different promising treatment modalities, such as melatonin and erythropoietin. However, preclinical studies and clinical trials are still needed to further elucidate the mechanisms of action of these modalities.

Citace poskytuje Crossref.org

Bibliografie atd.

Literatura

000      
00000naa a2200000 a 4500
001      
bmc21028103
003      
CZ-PrNML
005      
20230112102108.0
007      
ta
008      
211105s2020 xr a f 000 0|eng||
009      
AR
024    7_
$a 10.33549/physiolres.934595 $2 doi
035    __
$a (PubMed)33464921
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xr
100    1_
$a Frajewicki, Ari $7 xx0272248 $u Institute of Physiology, First Faculty of Medicine, Charles University, Prague, Czech Republic
245    10
$a Perinatal hypoxic-ischemic damage: review of the current treatment possibilities / $c A. Frajewicki, Z. Laštůvka, V. Borbélyová, S. Khan, K. Jandová, K. Janišová, J. Otáhal, J. Mysliveček, V. Riljak
504    __
$a Literatura
520    9_
$a Neonatal hypoxic-ischemic encephalopathy is a disorder with heterogeneous manifestation due to asphyxia during perinatal period. It affects approximately 3-12 children per 1000 live births and cause death of 1 million neonates worldwide per year. Besides, motor disabilities, seizures, impaired muscle tone and epilepsy are few of the consequences of hypoxic-ischemic encephalopathy. Despite an extensive research effort regarding various treatment strategies, therapeutic hypothermia with intensive care unit supportive treatment remains the only approved method for neonates who have suffered from moderate to severe hypoxic-ischemic encephalopathy. However, these protocols are only partially effective given that many infants still suffer from severe brain damage. Thus, further research to systematically test promising neuroprotective treatments in combination with hypothermia is essential. In this review, we discussed the pathophysiology of hypoxic-ischemic encephalopathy and delved into different promising treatment modalities, such as melatonin and erythropoietin. However, preclinical studies and clinical trials are still needed to further elucidate the mechanisms of action of these modalities.
650    _2
$a látky tlumící činnost CNS $x terapeutické užití $7 D002492
650    _2
$a erythropoetin $x terapeutické užití $7 D004921
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a hypoxie $x komplikace $x farmakoterapie $x patofyziologie $7 D000860
650    _2
$a mozková hypoxie a ischemie $x farmakoterapie $x etiologie $x patofyziologie $7 D020925
650    _2
$a novorozenec $7 D007231
650    _2
$a melatonin $x terapeutické užití $7 D008550
650    _2
$a těhotenství $7 D011247
655    _2
$a časopisecké články $7 D016428
655    _2
$a přehledy $7 D016454
700    1_
$a Laštůvka, Zdeněk $7 xx0266816 $u Institute of Physiology, First Faculty of Medicine, Charles University, Prague, Czech Republic
700    1_
$a Borbélyová, Veronika, $d 1988- $7 xx0239793 $u Institute of Molecular Biomedicine, Faculty of Medicine, Comenius University, Bratislava, Slovak Republic
700    1_
$a Khan, Sami $7 _AN112266 $u Institute of Physiology, First Faculty of Medicine, Charles University, Prague, Czech Republic
700    1_
$a Jandová, Kateřina, $d 1970- $7 xx0056834 $u Institute of Physiology, First Faculty of Medicine, Charles University, Prague, Czech Republic
700    1_
$a Janišová, Kateřina $7 xx0267033 $u Institute of Physiology, First Faculty of Medicine, Charles University, Prague, Czech Republic
700    1_
$a Otáhal, Jakub $7 xx0105144 $u Institute of Physiology of the Czech Academy of Sciences, Prague, Czech Republic
700    1_
$a Mysliveček, Jaromír, $d 1968- $7 nlk19990073583 $u Institute of Physiology, First Faculty of Medicine, Charles University, Prague, Czech Republic
700    1_
$a Riljak, Vladimír $7 xx0081611 $u Institute of Physiology, First Faculty of Medicine, Charles University, Prague, Czech Republic
773    0_
$w MED00003824 $t Physiological research $x 1802-9973 $g Roč. 69, Suppl 3 (2020), s. S379-S401
773    0_
$t Proceedings of the ... Physiological days $x 1802-9973 $g Roč. 96, Suppl 3 (2020), s. S379-S401 $w MED00183838
856    41
$u https://pubmed.ncbi.nlm.nih.gov/33464921 $y Pubmed
910    __
$a ABA008 $b A 4120 $c 266 $y p $z 0
990    __
$a 20211105 $b ABA008
991    __
$a 20230112102102 $b ABA008
999    __
$a ok $b bmc $g 1728716 $s 1148648
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2020 $b 69 $c Suppl 3 $d S379-S401 $e 20201231 $i 1802-9973 $m Physiological research $n Physiol. Res. (Print) $x MED00003824
BMC    __
$a 2020 $b 96 $c Suppl 3 $d S379-S401 $e 20201231 $i 1802-9973 $m Proceedings of the ... Physiological days $x MED00183838
LZP    __
$b NLK118 $a Pubmed-20211105

Najít záznam

Citační ukazatele

Možnosti archivace